Safety of antiretroviral drugs
Human immunodeficiency virus (HIV), isolated in 1983 by Paster Institute researches, has been recognised as the cause of million fatalies in 21st century. Initial monotherapy failed to show promising results, however, with the development of highly active antiretroviral therapy new era of HIV treatm...
Main Authors: | Anđelković Milena, Buha Aleksandra, Vukomanović Predrag, Matović Vesna |
---|---|
Format: | Article |
Language: | srp |
Published: |
Pharmaceutical Association of Serbia, Belgrade, Serbia
2016-01-01
|
Series: | Arhiv za farmaciju |
Subjects: | |
Online Access: | https://scindeks-clanci.ceon.rs/data/pdf/0004-1963/2016/0004-19631604161A.pdf |
Similar Items
-
The PHACS SMARTT Study: Assessment of the Safety of In Utero Exposure to Antiretroviral Drugs
by: Russell Barrett Van Dyke, et al.
Published: (2016-05-01) -
Highly active antiretroviral therapy induced adverse drug reactions in Indian human immunodeficiency virus positive patients (RETRACTED by plagiarism)
by: Rajesh R, et al.
Published: (2011-03-01) -
Drug-drug interactions between antiretrovirals and bedaquiline
by: Pandie, Mishal
Published: (2018) -
Antiretroviral Drugs Impact Autophagy with Toxic Outcomes
by: Laura Cheney, et al.
Published: (2021-04-01) -
Adverse effects of antiretroviral therapy in pregnant women infected with HIV in Brazil from 2000 to 2015: a cohort study
by: Adriane M. Delicio, et al.
Published: (2018-09-01)